BioWorld Asia

April 1, 2009

Intercell Gets Stock Boost as FDA Approves Ixiaro

Shares in Intercell AG received a significant boost Tuesday on news that the FDA approved its Japanese Encephalitis Virus (JEV) vaccine Ixiaro late Monday. (BioWorld International) Read More

BioVex Raises $40M to Fund Melanoma Vaccine Study

More Breast Cancer Genes to Boost Genetic Screening

EU Animal Directive Draws Ire from UK Researchers

Survey Points to Trouble Raising Funds in the UK

TcLand, Genedata Collaborate on Autoimmune Biomarkers

Newron Moves Ralfinamide into Pivotal Pain Trials

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 25, 2026.

Have brain-computer interfaces finally arrived?

BioWorld

More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 23, 2026

Brain-computer interfaces are here but long road ahead

BioWorld

The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...

2026 marks critical turning point for BCI technology

BioWorld

Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...